You are here

Yoram Groner

Pre-leukemic stem cells (top) with both mutated and healthy copies of the RUNX1 gene already display some of the characteristics of acute myeloid leukemia (AML). When the non-mutated copy of the gene is inactivated, disruptions in the spindle-assembly-checkpoint phase of cell division trigger cell death
29.09.2013

Weizmann Institute researchers discover that a “standoff” between a mutated gene and its normal counterpart keeps certain cancer cells alive...

Prof. David Wallach
22.03.1998
REHOVOT, Israel - March 22, 1998 - Prof. David Wallach of the Weizmann Institute of Science's Biological Chemistry Department has...
Adult Onset Diabetes: An 'Imbalancing' Act
01.10.1997
Although diabetes is the Western world's most common metabolic disease, adult-onset diabetes, which affects 90% of diabetes...
Dr. Ditsa Levanon
23.03.2017

Discovering the workings of our “sixth sense” 

Prof. Yoram Groner
12.09.2010
Genetically engineered human SOD, manufactured based on Prof. Yoram Groner's research, is now undergoing clinical trials
...
Prof. Yoram Groner.
01.05.2009

Prof. Yoram Groner is a pioneer in Down syndrome research

...
Profs. Karen Avraham and Yoram Groner.
01.10.2007

Prof. Karen Avraham researches the genetic causes of deafness

...
 Introduction
01.09.2004

A new era is dawning in the battle against cancer. In the more than 30 years that have elapsed since U.S. President Richard...

At the Weizmann Institute
01.05.2004
Long dedicated to battling diabetes, researchers at the Weizmann Institute of Science are studying all aspects of this...
Prof. Yoram Groner
01.11.2001

Prof. Yoram Groner
...

Pages